J&J Relaunches Johnson’s Baby Care As Greener, Gentler, With Fewer Ingredients
This article was originally published in The Rose Sheet
Executive Summary
The overhaul in line with “modern parents’ preferences” could be what’s needed to rouse the sleepy brand and spur Consumer business growth.
You may also be interested in...
J&J's CEO Gorsky Steps Aside With Duato Named His Successor
J&J's CEO Alex Gorsky is stepping down after almost 10 years in the role and will be replaced by vice chairman of the executive committee Joaquin Duato.
J&J International Baby, Beauty Lines Could Lead Trimming 10% Of Consumer Portfolio
J&J plans to cut 10% of its consumer health portfolio, with most divestitures in the baby and beauty care segments outside the US. It plans to focus on growing “stronghold” categories of skin health and self care, including Aveeno and Tylenol.
Rapid Release Gels, Arthritis Formulation Put Tylenol In US OTC Analgesic Lead
Tylenol brand consumption grows 10% on sales of Rapid Release Gel and Tylenol Arthritis, reaching top spot among analgesic products in the US, J&J says. Retailers' inventory builds as a result of prior-year supply constraints driven by Hurricane Maria also helped drive growth.